Antiinflammatory activity of melatonin in central nervous system.

Esposito E, Cuzzocrea S. · 2010

Read Antiinflammatory activity of melatonin in central nervous system. by Esposito E, Cuzzocrea S. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3001216.txt.

Introduction

Esposito and Cuzzocrea reviewed melatonin's calming effects on inflammation in the brain and nervous system in a 2010 article. The hormone, made mainly by the pineal gland at night but also in gut, eye, and other tissues, is best known for daily rhythm control.

Beyond rhythm, melatonin tempers immune cells, lowers inflammatory messengers and sticking molecules, and fights oxidative damage both directly and by boosting protective enzymes. Trials and lab work suggest benefit in several brain disorders where inflammation and oxidation intertwine. The review collects evidence across those diseases and weighs melatonin as a protective treatment.

Catalog record

CREATOREsposito E, Cuzzocrea S.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE103 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC3001216

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Antiinflammatory Activity of Melatonin in Central Nervous System By Emanuela Esposito, Salvatore Cuzzocrea Published in: Current Neuropharmacology DOI: 10.2174/157015910792246155 ABSTRACT Abstract Melatonin is mainly produced in the mammalian pineal gland during the dark phase. Its secretion from the pineal gland has been classically associated with circadian and circanual rhythm regulation. However, melatonin production is not confined exclusively to the pineal gland, but other tissues including retina, Harderian glands, gut, ovary, testes, bone marrow and lens also produce it. Several studies have shown that melatonin reduces chronic and acute inflammation. The immunomodulatory properties of melatonin are well known; it acts on the immune system by regulating cytokine production of immunocompetent cells. Experimental and clinical data showing that melatonin reduces adhesion molecules and pro-inflammatory cytokines and modifies serum inflammatory parameters. As a consequence, melatonin improves the clinical course of illnesses which have an inflammatory etiology. Moreover, experimental evidence supports its actions as a direct and indirect antioxidant, scavenging free radicals, stimulating antioxidant enzymes, enhancing the activities of other antioxidants or protecting other antioxidant enzymes from oxidative damage. Several encouraging clinical studies suggest that melatonin is a neuroprotective molecule in neurodegenerative disorders where brain oxidative damage has been implicated as a common link. In this review, the authors examine the effect of melatonin on several neurological diseases with inflammatory components, including dementia, Alzheimer disease, Parkinson disease, multiple sclerosis, stroke, and brain ischemia/reperfusion but also in traumatic CNS injuries (traumatic brain and spinal cord injury) Keywords: Melatonin, inflammation, neurodegeneration, mitochondria, antioxidant, free radical. INTRODUCTION Brain tissue is very vulnerable to free radical damage because of its high oxygen utilization (20% of the total oxygen inspired), high concentrations of polyunsaturated fatty acids [57] and transition metals such as iron, which is involved in the generation of the hydroxyl radical [76], and low concentrations of cytosolic antioxidants [44, 56, 152]. Glutathione (GSH) is the predominant antioxidant in the brain that is present at millimolar concentrations [174]. Melatonin, a secretory product of the pineal gland, is a ubiquitously acting direct free radical scavenger and also an indirect antioxidant [6, 197]. Melatonin, as well as its metabolites, are efficient in detoxifying reactive oxygen species (ROS), e.g., HO• and H2O2 [194], and they also interact directly with reactive nitrogen species (RNS) [32, 68, 146, 196]. Endogenous melatonin is synthesized in the pineal gland from the neurotransmitter serotonin in a circadian manner. In mammals, the melatonin rhythm is generated by an endogenous circadian master clock in the suprachiasmatic nucleus (SCN) of the hypothalamus, which is entrained by the light/dark cycle over a 24-hr period. It participates in several neuroendocrine and physiological processes and is appropriately referred to as a tissue factor, a paracoid, an autocoid, and an anti-oxidant and sometimes as a hormone depending on its physiological actions [192]. It has profoundanti-oxidant actions against oxidative and nitrosative stress [159]. It also exerts significant immunomodulatory influences [189] and modulates angiogenesis and wound healing processes [181]. Melatonin exerts its effects through receptor-mediated and receptor-independent mechanisms, thus, manifesting enormous functional versatility and diversity [160]. The ubiquitous distribution of melatonin receptors in the CNS as well as in the peripheral organs further compliments the fact that melatonin’s actions are not compromised by morpho-physiological barriers such as the blood-brain barrier. It is likely to influence every cell with which it comes into contact. At physiological concentrations, melatonin exerts receptor-mediated actions whereas the receptor-independent actions usually require higher supraphysiological/pharmacological melatonin concentrations because of the circumstances under which it is tested. Even at the higher concentrations, melatonin is well-tolerated by humans [176]. Two melatonin receptors, MT1 and MT2, which belong to the G-protein-coupled receptor superfamily, have been cloned in mammals and share some specific short amino-acid sequences, suggesting that they represent a specific subfamily. A third melatonin-binding site has been purified and characterized as the enzyme quinine reductase 2, and the inhibition of this enzyme by melatonin may contribute to its anti-oxidant properties [138, 195]. Exogenous administration of melatonin can also entrain the circardian clock by a direct action on SCN and, thus, it has potential to treat the disoriented circardian clock in cases such as jet-lag, shift-work, in profoundly blind subjects, and in individuals with delayed or advanced sleep phase syndromes and sleep inefficiency [72]. Besides being used to increase sleep efficiency, treat jet lag, improve the cardiovascular system [177], and as an antiaging drug [21, 71, 167] and a dietary supplement and cancerprotective hormone [149], intensive research has indicated melatonin’s beneficial effects in experimental models of neurodegenerative disorders. Brain oxidative damage has been implicated as a common link in the pathogenesis of such diseases. MELATONIN AND ITS RECEPTORS Melatonin (N-acetyl-5-methoxytryptamine) is a natural hormone secreted by the pineal gland. In clinical use for many years, melatonin is safe and well-tolerated even at high doses [214]. Melatonin, or N-acetyl-5-methoxytryptamine, is an indole mainly produced in the mammalian pineal gland during the dark phase. Melatonin secretion from the pineal gland has been classically associated with circadian and circanual rhythm regulation, and with adjustments of physiology of animals to seasonal environmental changes [151]. Melatonin production, however, is not confined exclusively to the pineal gland, but other organs and tissues including retina, Harderian glands, gut, ovary, testes, bone marrow and lens also have been reported to produce it [128, 193]. In recent years, it has become apparent that melatonin’s actions transcended those of a hormonal modulator. Melatonin had been shown to subtly influence the function of a variety of tissues and cells not generally considered in the endocrine category [193]. This led to a suspicion that melatonin had yet undefined actions at the cellular level. Numerous data suggest a role for melatonin and its metabolites function in the antioxidative defence in all organisms that produce this indole [120, 158, 168, 196], particularly, since melatonin crosses all morphophysiological barriers and enters all cells. Several mechanisms have been proposed for the neuroprotective effect of melatonin. Melatonin upregulates antioxidative defensive systems, including the activities of superoxide dismutase and glutathione peroxidase as well as the levels of glutathione [202]. Furthermore, melatonin and its metabolites scavenge free radicals [147, 190] and thus terminate the initiation and propagation of lipid peroxidation. A recent studies show that melatonin binds several metals, including iron [107, 108] and this effect may attenuate the Fenton reaction and the generation of the hydroxyl radical. It participates crucially in neurogenesis, immunomodulation [182, 200], improving immune defense [118], regulating circadian rhythms and sleep [1], eliminating free radicals [146, 155, 156, 196], intervening in lipid metabolism [119, 173], and also inhibiting cancer growth [61]. Mechanistically, melatonin functions, by acting through G-protein coupled membrane receptors, MT1 and MT2 [61, 119, 173] and through nuclear receptors RZR/ROR [142]. Melatonin also stimulates a host of antioxidative enzymes including SOD, glutathione peroxidase (GPx) and glutathione reductase (GRd); these actions further reduce the oxidation state of cells [6, 122]. Melatonin inhibits the activity of nitric oxide synthase and dopamine release, potentiates the inhibitory effect of GABA in the central nervous system, modulates the serotonin receptors and potentiates the opioid analgesic. Melatonin possesses an electron-rich aromatic indole ring and functions as an electron-donor, thereby reducing and repairing electrophilic radicals [124]. Of additional interest regarding melatonin, is its reported binding to quinone reductase 2 [217]. This enzyme, which is considered

Read the complete text